local
Popular drug used to treat epilepsy, bipolar disorder recalled nationwide: Here's why
Summary by The El Paso Editorial Desk · Based on reporting by Matthew Euzarraga , KTSM 9 News (NBC)
· July 24, 2026
· 1 min read
A popular prescription medication used nationwide to treat epilepsy and bipolar disorder is being recalled, according to a Food and Drug Administration enforcement report.
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Original reporting Matthew Euzarraga, KTSM 9 News (NBC) Original story Read at the source Source published Jul 24, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Why this matters in The El Paso
The recall of this popular prescription medication has significant implications for El Paso residents who rely on it to manage their epilepsy and bipolar disorder. Local pharmacies and healthcare providers will need to take immediate action to notify patients and provide alternative treatment options. This recall may also put a strain on the local healthcare system, particularly if a large number of patients need to be switched to different medications or undergo additional monitoring. El Pasoans who take this medication should be vigilant about checking their prescription labels and consulting with their doctors to determine the best course of action. The city's health department and medical community will likely be working closely together to ensure a smooth transition and minimize disruptions to patient care.
About this story
Original reporting by KTSM 9 News (NBC) . The El Paso surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KTSM 9 News (NBC) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 24, 2026 ·
Source: KTSM 9 News (NBC) ·
Reading time: 1 min
Frequently asked about this story
What is this story about? A popular prescription medication used nationwide to treat epilepsy and bipolar disorder is being recalled, according to a Food and Drug Administration enforcement report.
When was this published? This article was first published on July 24, 2026 by KTSM 9 News (NBC) and curated for The El Paso readers.
Who reported this story? This story was reported by Matthew Euzarraga at KTSM 9 News (NBC). To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter